Critical Care Services Updates: October 2010

http://www.nursingcenter.com/library/JournalArticle.asp?Article_ID=1047254

Arixtra-the new Prophylaxis for DVT/PE

Heparinoids: Atrixia
Heparinoids are possibly the newest class of anticoagulants. Currently, there is only one drug in this class, Atrixia. Atrixia is a subcutaneous injection that is give once a day. It is usually used short term (only 5-9 days). It is the only anticoagulant that inhibits only factor Xa and does not affect thrombin.
Atrixia is typically taken once daily
Atrixia is new and therefore may be expensive
Atrixia is another anticoagulant option
Suggested links
ARIXTRAARIXTRA offers simplified anticoagulation for a broad range of indications, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Use ARIXTRA for prophylaxis of venous thromboembolism (VTE) after major orthopedic surgery, hip fracture surge

Respecting those you don't respect-From Crucial Converstations Blog

Dialogue requires Mutual Respect, but this doesn’t mean you can only maintain dialogue with your buddies or with people you really admire. You can respect even those you mistrust or dislike.
Respect doesn’t require solid friendships…but it does call for the ability to see the humanity in others. It means that we see others as worthy of the civility we owe any human being—that no matter what happens in the conversations, we’re not going to violate the other person’s dignity. Period.

Friday, October 22, 2010

CEU review of Anticoagulants

Arixtra-the new Prophylaxis for DVT/PE

Critical Care sites

Listen to Quint Studer on MSNBC

Respecting those you don't respect-From Crucial Converstations Blog

Sunset

Blog Archive

Savor the waning sun

Contributors